載入...
Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy
<p><strong>Background.</strong> Therapy for metastatic castration-resistant prostate cancer (CRPC) is a serious problem that requires significant public health care expenditures.</p><p><strong>Objective</strong>: to evaluate the cost-effectiveness of abirate...
Na minha lista:
Main Authors: | , , |
---|---|
格式: | Artigo |
語言: | Russo |
出版: |
ABV-press
2014-11-01
|
叢編: | Onkourologiâ |
主題: | |
在線閱讀: | http://oncourology.abvpress.ru/index.php/oncur/article/view/383 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|